The 2016 WHO CNS tumor classification included molecular features, particularly isocitrate dehydrogenase (IDH), which is divided into IDH mutant(IDH-M)and IDH wild type(IDH-W),on a histological basis for the first time and used it as one of the important bases for molecular typing of gliomas (7, 8). This evidence concerns the gene IDH3A and glioma.